Ars Technica1 min read
The $15 billion ad-powered AI startup your doctor may already be using
OpenEvidence is booming despite questions about accuracy and ads.
By Rafe Rosner-Uddin, Financial TimesArs Technica

Read the full story
Originally published by Ars Technica on Oct 21, 2026.
Comments
Sign in to join the discussion.